Media-OutReach Newswire Two Out of Three Rare Disease Patients in Asia-Pacific Do Not Receive the Best-available Care, According to an Economist Intelligence Unit Survey
Media-OutReach Newswire The Lancet Neurology publishes positive results of AFFiRiS' Phase 1 trial with PD01A in Parkinson’s disease patients
Media-OutReach Newswire Stronger together in a post-COVID-19 world: PSB Academy and Australian universities renew long-term partnerships for five more years
Media-OutReach Newswire Abivax: ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory epithelium model
Media-OutReach Newswire Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial
Media-OutReach Newswire Vetter's High Performance is Again Recognized at the 2020 CMO Leadership Awards